- Home
- VRAR vs TURN Comparison
VRAR vs TURN Comparison
Compare VRAR & TURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAR
- TURN
- Stock Information
- Founded
- VRAR 2016
- TURN 1981
- Country
- VRAR United States
- TURN United States
- Employees
- VRAR N/A
- TURN N/A
- Industry
- VRAR Retail: Computer Software & Peripheral Equipment
- TURN Finance/Investors Services
- Sector
- VRAR Technology
- TURN Finance
- Exchange
- VRAR Nasdaq
- TURN Nasdaq
- Market Cap
- VRAR 42.4M
- TURN 35.4M
- IPO Year
- VRAR 2021
- TURN N/A
- Fundamental
- Price
- VRAR $1.95
- TURN $3.97
- Analyst Decision
- VRAR Strong Buy
- TURN
- Analyst Count
- VRAR 1
- TURN 0
- Target Price
- VRAR $4.67
- TURN N/A
- AVG Volume (30 Days)
- VRAR 5.7M
- TURN 39.4K
- Earning Date
- VRAR 02-12-2025
- TURN 02-18-2025
- Dividend Yield
- VRAR N/A
- TURN N/A
- EPS Growth
- VRAR N/A
- TURN N/A
- EPS
- VRAR N/A
- TURN N/A
- Revenue
- VRAR $8,137,688.00
- TURN $129,297.00
- Revenue This Year
- VRAR $39.02
- TURN N/A
- Revenue Next Year
- VRAR N/A
- TURN N/A
- P/E Ratio
- VRAR N/A
- TURN N/A
- Revenue Growth
- VRAR N/A
- TURN 6.32
- 52 Week Low
- VRAR $0.50
- TURN $3.12
- 52 Week High
- VRAR $7.00
- TURN $4.47
- Technical
- Relative Strength Index (RSI)
- VRAR 46.96
- TURN 70.45
- Support Level
- VRAR $1.86
- TURN $3.55
- Resistance Level
- VRAR $2.17
- TURN $3.67
- Average True Range (ATR)
- VRAR 0.38
- TURN 0.13
- MACD
- VRAR -0.16
- TURN 0.02
- Stochastic Oscillator
- VRAR 14.41
- TURN 88.52
About VRAR The Glimpse Group Inc.
The Glimpse Group Inc is a diversified Virtual and Augmented Reality platform company, comprised of multiple VR and AR software and services companies, and designed with the specific purpose of cultivating companies in the emerging VR/AR industry.
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.